AGMB
AgomAb Therapeutics NV
8.70$
+1.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +21.1% | +6.7% | -22.6% | |
| – | +90.5% | +23.4% | -57.5% | |
| – | +30.0% | +7.6% | -28.5% | |
| – | – | – | – | |
| – | -20.0% | +12.1% | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.